ISSN 2327-2236
Vol. 2, Issue 2, 2015May 06, 2015 EDT
Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infection (C. difficile-associated diarrhoea) in Ireland
Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infection (C. difficile-associated diarrhoea) in Ireland
Articles in Vol. 2, Issue 2, 2015
Vol. 2, Issue 2, 2015
- Comparing Prednisone and Methotrexate to Off-label Biologic Infliximab for Management of Ocular Uveitis: A Cost-minimization AnalysisWilliam V. PadulaMiguel Cordero-ComaTaygan YilmazWilliam V. PadulaMichéal J. GallagherJonathan D. Campbell
- Real-World Treatment Patterns in Men with Castration- Resistant Prostate Cancer Receiving DocetaxelKeith L. DavisBenjamin GutierrezTeresa ZyczynskiJames A. Kaye
- Traumatic Brain Injury: Patient Characteristics, Hospital Costs and Trends Over TimePankaj A. PatelPeter J. MallowMary VassarJohn A. RizzoBhavik J. PandyaDenise T. Kruzikas
- A Criterion-based Approach for the Systematic and Transparent Extrapolation of Clinical Trial Survival DataGabriel TremblayPatrick HainesAndrew Briggs
- Cost Analysis and Clinical Outcomes of Ambulatory Care Monitoring in Medicare Patients: Describing the Diagnostic OdysseyRenée JG ArnoldAndrew Layton
- The Cost of an Operating Room Minute for Heart Valve ProceduresEugene A. GrossiMatthew MoorePeter J. MallowJohn A. Rizzo
- Treatment Interruption and Regimen Change in Firstgeneration versus Second-generation Tyrosine Kinase Inhibitors used as First-line Therapy for Chronic Myeloid LeukemiaMelea A. WardGang FangKristy L. RichardsChristine M. WalkoStephanie R. EarnshawLaura E. HappeSusan J. Blalock
- Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infection (C. difficile-associated diarrhoea) in IrelandAnke van EngenMontserrat CasamayorFidelma LoftusMartin CoenAndy GarnhamMaureen WattLarry Lacey
- Japanese Patients’ and Physicians’ Preferences for Anticoagulant Use in Atrial Fibrillation: Results from a Discrete-choice ExperimentKen OkumuraHiroshi InoueMasahiro YasakaJuan Marcos GonzalezA. Brett HauberBennett LevitanZhong YuanJean Baptiste Briere
- Comparison of Real-world Outcomes Between Patients Treated with Tapentadol ER or Oxycodone CRMike DurkinJacqueline PesaJessica LopattoRachel HalpernDamon Van VoorhisStephanie Korrer
1.
van Engen A, Casamayor M, Loftus F, et al. Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infection (C. difficile-associated diarrhoea) in Ireland. JHEOR. 2015;2(2):192-206. doi:10.36469/9903
